QT
EWTX icon

Quantbot Technologies’s Edgewise Therapeutics EWTX Stock Holding History

Quantbot Technologies’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-774
Closed -$19.2K – 1835
2025
Q4 		$19.2K Buy
+774
New +$15.5K ﹤0.01% 1569
2025
Q3 		– Sell
-41,463
Closed -$544K – 1847
2025
Q2 		$544K Buy
+41,463
New +$598K 0.01% 983
2025
Q1 		– Sell
-3,855
Closed -$103K – 1601
2024
Q4 		$103K Buy
+3,855
New +$123K ﹤0.01% 1193
2024
Q2 		– Sell
-8,009
Closed -$146K – 1588
2024
Q1 		$146K Buy
8,009
+6,084
+316% +$96.7K 0.01% 1089
2023
Q4 		$21.1K Sell
1,925
-775
-29% -$5.44K ﹤0.01% 1426
2023
Q3 		$15.5K Buy
+2,700
New +$18.4K ﹤0.01% 1370
2023
Q1 		– Sell
-1,300
Closed -$11.6K – 1697
2022
Q4 		$11.6K Hold
1,300
– – ﹤0.01% 1496
2022
Q3 		$12K Buy
1,300
+500
+63% +$5.05K ﹤0.01% 1409
2022
Q2 		$6K Hold
800
– – ﹤0.01% 1573
2022
Q1 		$7K Buy
+800
New +$10.3K ﹤0.01% 1494

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Quantbot Technologies's EWTX Position: Q1 2026 in Review

Quantbot Technologies sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 774 shares — an estimated $19.2K sold.

Quantbot Technologies first reported a position in EWTX in Q1 2022 and held it in 10 quarters. The position peaked at $544K in Q2 2025. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Quantbot Technologies reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 774 Edgewise Therapeutics shares in Q1 2026, an estimated $19.2K.
  • Quantbot Technologies first reported a position in Edgewise Therapeutics in Q1 2022 and held it in 10 quarters.
  • Quantbot Technologies's Edgewise Therapeutics position peaked at $544K in Q2 2025.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.